Eradication of poliomyelitis in the United States: a commentary on the Salk reviews.
D000917:Antibody Formation; D004196:Disease Outbreaks; D006801:Humans; D011051:Poliomyelitis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects / Q000145:classification* / Q000627:therapeutic use; D014481:United States; D014611:Vaccination / Q000009:adverse effects / Q000191:economics / Q000639:trends*
D011054:Poliovirus Vaccine, Inactivated